Pfizer, Amazon, President Trump, football, social injustice, global warming, American Airlines, racism | Dallas News

The shady nature of drug pricing was well illustrated in the news about the outcome of the Pfizer lawsuit against the Texas Health and Human Services Commission. Pfizer had filed a lawsuit for disclosing drug pricing and rebate information to two Texas legislators who were outside the inner circle of “need to know” individuals. Unsurprisingly, the judge ruled that the legislators did, in fact, need to know this information to “exercise meaningful oversight”  in the administration of the Medicaid program, the state’s largest expense.

Pfizer’s response and resolve to maintain the covertness of its pricing and rebate information begs some questions as to what pharmaceutical companies may be hiding from consumers. Texas may have something to learn from the 11 other states that have taken action in demanding increased price transparency.

Why should complex negotiations/discounts between various entities remain so secretive? “Value based pricing,” or strategic pricing based on the maximum financial gain anticipated from the most vulnerable and sick individuals, is clearly something Pfizer is eager to continue keeping concealed.

Read complete article here:

Pfizer, Amazon, President Trump, football, social injustice, global warming, American Airlines, racism | Letters to the Editor | Dallas News.